“Discovery of PF-06463922, a Macrocycli

“Discovery of PF-06463922, a Macrocyclic Inhibitor of ALK/ROS1 with Preclinical Brain Exposure and Broad Spectrum Potency against ALK-resistant Mutations” – Dr. Ted W. Johnson, Pfizer La Jolla – 17th Annual MedChem Symposium on Friday, July 18 – Register today! http://chemistry.ucsd.edu/go/medchem

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: